PEHSU Grand Rounds Webinar
This webinar is part of an ongoing series of educational presentations by experts on issues that focus on current and emerging aspects of pediatric and reproductive environmental health.
Herbal Products and Related Toxicity - August 21, 2019
- Understand the DSHEA regulation and amendments
- Discuss contamination and quality issues with herbal supplements
- Know the herbs most likely to cause Type I allergic reactions
- Describe the liver toxicity from pennyroyal and kava kava
- Describe the CNS toxicity from alpha lipoic acid
- Explain several toxicological problems with Ginkgo biloba
Presenter: Susan C. Smolinske, PharmD, DABAT, FACCT
Dr. Smolinske graduated with a BS in Pharmacy from the University of Florida and PharmD from Idaho State University. She has been a diplomat of ABAT since 1996, is a fellow of AACT, and is currently the Director of the New Mexico Poison & Drug Information Center and a Professor in Pharmacy Practice and Administration at the University of New Mexico. She has written a book on toxicity of houseplants and conducted original research on the toxicity of dietary supplements. She is a consultant for both ToxED and webPOISONCONTROL and has written numerous triage and treatment documents on both plants and herbal medicines. She has authored a chapter in Yaffe & Aranda's Neonatal and Pediatric Pharmacology: Therapeutic Principles in Practice for the last two editions and has a recent review article in Pediatric Clinics of North American regarding dietary supplement use in children.
Continuing Education Information
To receive continuing education (CE) for WC2588-082119 - PEHSU Grand Round Series - Herbal Products and Related Toxicity - August 21, 2019 (Webcast) you must first establish a login with the CDC and follow the steps below. Click here to access the CDC Training and Continuing Education Online webpage
- View recorded webinar on the PEHSU National Classroom
- Please visit TCEO and follow these 9 Simple Steps before September 23, 2019.
- Search for the activity: WC2588-082119
- Complete the Evaluation at www.cdc.gov/TCEOnline
- Pass the posttest at 80% on TCEO (Posttest consists of a mix of five multiple choice and true/false questions.)
- CE certificates will be available on your TCEO account
FEES: No fees are charged for CDC’s CE activities.